Advertisement

Click here for more guidelines.
2012 ACCF/ AATS/ SCAI/ STS Expert Consensus Document on Transcatheter Aortic Valve Replacement
ACCF/ SCAI/ STS/ AATS/ AHA/ ASNC/ HFSA/ SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update
2012 ACCF/ AHA/ ACR/ SCAI/ SIR/ STS/ SVM/ SVN Key Data Elements and Definitions for Peripheral Atherosclerotic Vascular Disease

 
About JACC CME
Policy on Privacy and Confidentiality
Disclosures
Important Information
 

JACC Imaging Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?
Click here
to sign up now!

Submit Manuscripts
Author Information
Subscribe/Renew
Order Reprints
Email Alerts
Feedback
RSS Feed
CME
 
 

Cardiosmart
Cardiosource
CVN
Imaging Library
JACC Imaging
JACC Interventions
 
 

About the Journal
Editorial Board & Staff
 
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2007; 49:1924-1930, doi:10.1016/j.jacc.2007.01.081 (Published online 30 April 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.01.081v1
49/19/1924    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menichelli, M.
Right arrow Articles by Violini, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menichelli, M.
Right arrow Articles by Violini, R.
Related Collections
Right arrowRelated Articles

CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY

Randomized Trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI)

Maurizio Menichelli, MD*,*, Antonio Parma, MD*, Edoardo Pucci, MD*, Rosario Fiorilli, MD*, Francesco De Felice, MD*, Marco Nazzaro, MD*, Alessia Giulivi, MD*, Domenico Alborino, MD*, Arianna Azzellino, PhD{dagger} and Roberto Violini, MD*

* Division of Interventional Cardiology, San Camillo Hospital, Rome, Italy
{dagger} Politecnico Milano, Milan, Italy

Manuscript received October 31, 2006; revised manuscript received January 11, 2007, accepted January 16, 2007.

* Reprint requests and correspondence: Dr. Maurizio Menichelli, Department of Cardiology, San Camillo Hospital, Circ. Gianicolense 187, 00100 Rome, Italy. (Email: menichelli747{at}yahoo.com).

Objectives: To confirm whether sirolimus-eluting stents (SES) safely reduce the incidence of restenosis in patients with ST-segment elevation acute myocardial infarction compared with bare-metal stents (BMS).

Background: In the setting of primary angioplasty, stent restenosis occurs in up to 27% of patients. The introduction of drug-eluting stents has drastically reduced the incidence of restenosis in clinically stable patients.

Methods: We conducted a randomized trial of 320 patients with acute ST-segment elevation myocardial infarction assigned to receive SES or BMS. The primary end point was binary restenosis at 1-year angiographic follow-up.

Results: At 1 year, the incidence of binary restenosis was lower in the SES group than in the BMS group (9.3% vs. 21.3%, respectively; p = 0.032), as were the rates of target lesion revascularization (4.3% vs. 11.2%; p = 0.02), target vessel revascularization (5% vs. 13.1; p = 0.015), major adverse cardiac events (6.8% vs. 16.8%; p = 0.005), and target vessel failure (8.7% vs. 18.7%; p = 0.007). The incidence of angiographically documented stent thrombosis was 1.2% (n = 2) in the SES group and 0.6% (n = 1) in the BMS group.

Conclusions: In patients with acute myocardial infarction, SES are superior to BMS, reducing the incidence of binary restenosis by 56%, target lesion revascularization by 61%, target vessel revascularization by 62%, adverse cardiac events by 59%, and target vessel failure by 53% at 1 year. (Sirolimus Eluting Stenting in Acute Myocardial Infarction; http://www.clinicaltrials.gov/ct/show/NCT00288210; NCT00288210 [ClinicalTrials.gov] )

Abbreviations and Acronyms
  BMS = bare-metal stents
  MACE = major adverse cardiovascular events
  MI = myocardial infarction
  PCI = percutaneous coronary intervention
  SES = sirolimus-eluting stents
  TIMI = Thrombolysis In Myocardial Infarction
  TLR = target lesion revascularization
  TVF = target vessel failure
  TVR = target vessel revascularization


Related Articles

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2007 49: A27-A28. [Full Text] [PDF]

Drug-Eluting Stents for Acute Myocardial Infarction
H. Vernon Anderson, Richard W. Smalling, and Timothy D. Henry
J. Am. Coll. Cardiol. 2007 49: 1931-1933. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 CirculationHome page
G. D. Dangas, A. Caixeta, R. Mehran, H. Parise, A. J. Lansky, E. Cristea, B. R. Brodie, B. Witzenbichler, G. Guagliumi, J. Z. Peruga, et al.
Frequency and Predictors of Stent Thrombosis After Percutaneous Coronary Intervention in Acute Myocardial Infarction
Circulation, April 26, 2011; 123(16): 1745 - 1756.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc IntervHome page
B. Witzenbichler, J. Wohrle, G. Guagliumi, J. Z. Peruga, B. R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, K. L. Hood, H. Parise, et al.
Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Diabetic Patients With Acute Myocardial Infarction: The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial
Circ Cardiovasc Interv, April 1, 2011; 4(2): 130 - 138.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
C. Spaulding, E. Teiger, P. Commeau, O. Varenne, E. Bramucci, M. Slama, K. Beatt, A. Tirouvanziam, L. Polonski, P. R. Stella, et al.
Four-Year Follow-Up of TYPHOON (Trial to Assess the Use of the CYPHer Sirolimus-Eluting Coronary Stent in Acute Myocardial Infarction Treated With BallOON Angioplasty)
J. Am. Coll. Cardiol. Intv., January 1, 2011; 4(1): 14 - 23.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
M. A. Vink, M. T. Dirksen, M. J. Suttorp, J. G. P. Tijssen, J. van Etten, M. S. Patterson, T. Slagboom, F. Kiemeneij, and G. J. Laarman
5-Year Follow-Up After Primary Percutaneous Coronary Intervention With a Paclitaxel-Eluting Stent Versus a Bare-Metal Stent in Acute ST-Segment Elevation Myocardial Infarction: A Follow-Up Study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction With ST-Segment Elevation) Trial
J. Am. Coll. Cardiol. Intv., January 1, 2011; 4(1): 24 - 29.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
B. Brodie, Y. Pokharel, N. Fleishman, A. Bensimhon, G. Kissling, C. Hansen, S. Milks, M. Cooper, C. McAlhany, and T. Stuckey
Very Late Stent Thrombosis After Primary Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for ST-Segment Elevation Myocardial Infarction: A 15-Year Single-Center Experience
J. Am. Coll. Cardiol. Intv., January 1, 2011; 4(1): 30 - 38.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
K. M. Ziada, R. Charnigo, and D. J. Moliterno
Long-Term Follow-Up of Drug-Eluting Stents Placed in the Setting of ST-Segment Elevation Myocardial Infarction
J. Am. Coll. Cardiol. Intv., January 1, 2011; 4(1): 39 - 41.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Garg and P. W. Serruys
Coronary Stents: Current Status
J. Am. Coll. Cardiol., August 31, 2010; 56(10_Suppl_S): S1 - S42.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. Kaltoft, H. Kelbaek, L. Thuesen, J. F. Lassen, P. Clemmensen, L. Klovgaard, T. Engstrom, H. E. Botker, K. Saunamaki, L. R. Krusell, et al.
Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction: 3-Year Follow-Up of the Randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial
J. Am. Coll. Cardiol., August 17, 2010; 56(8): 641 - 645.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc IntervHome page
P. L. Sanchez, F. Gimeno, P. Ancillo, J. J. Sanz, J. H. Alonso-Briales, F. Bosa, I. Santos, J. Sanchis, A. Bethencourt, J. Lopez-Messa, et al.
Role of the Paclitaxel-Eluting Stent and Tirofiban in Patients With ST-Elevation Myocardial Infarction Undergoing Postfibrinolysis Angioplasty: The GRACIA-3 Randomized Clinical Trial
Circ Cardiovasc Interv, August 1, 2010; 3(4): 297 - 307.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
C. Spaulding, J. Rosencher, and O. Varenne
Use of drug eluting stents in ST segment elevation myocardial infarction
Heart, July 1, 2010; 96(13): 1073 - 1077.
[Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
Y. Cho, H. M. Yang, K. W. Park, W. Y. Chung, D. J. Choi, W. W. Seo, K. T. Jeong, S. C. Chae, M. Y. Lee, S. H. Hur, et al.
Paclitaxel- Versus Sirolimus-Eluting Stents for Treatment of ST-Segment Elevation Myocardial Infarction: With Analyses for Diabetic and Nondiabetic Subpopulation
J. Am. Coll. Cardiol. Intv., May 1, 2010; 3(5): 498 - 506.
[Abstract] [Full Text] [PDF]

Home page
 Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in MedicineHome page
M. Early and D. J. Kelly
The role of vessel geometry and material properties on the mechanics of stenting in the coronary and peripheral arteries
Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, March 1, 2010; 224(3): 465 - 476.
[Abstract] [PDF]

Home page
 J Am Coll CardiolHome page
R. Violini, C. Musto, F. De Felice, M. S. Nazzaro, A. Cifarelli, T. Petitti, and R. Fiorilli
Maintenance of Long-Term Clinical Benefit With Sirolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 3-Year Results of the SESAMI (Sirolimus-Eluting Stent Versus Bare-Metal Stent In Acute Myocardial Infarction) Trial
J. Am. Coll. Cardiol., February 23, 2010; 55(8): 810 - 814.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. Maehara, G. S. Mintz, A. J. Lansky, B. Witzenbichler, G. Guagliumi, B. Brodie, M. A. Kellett Jr, H. Parise, R. Mehran, and G. W. Stone
Volumetric Intravascular Ultrasound Analysis of Paclitaxel-Eluting and Bare Metal Stents in Acute Myocardial Infarction: The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Intravascular Ultrasound Substudy
Circulation, November 10, 2009; 120(19): 1875 - 1882.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
F. Wolf, F. Cademartiri, C. Loewe, A. Stadler, M. Weber, J. Lammer, and G. M. Feuchtner
Evaluation of Coronary Stents With 64-MDCT: In Vitro Comparison of Scanners From Four Vendors
Am. J. Roentgenol., September 1, 2009; 193(3): 787 - 794.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. V. Finn, G. Nakazawa, F. Kolodgie, and R. Virmani
Drug eluting or bare metal stent for acute myocardial infarction: an issue of safety?
Eur. Heart J., August 1, 2009; 30(15): 1828 - 1830.
[Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
E. Di Lorenzo, G. De Luca, R. Sauro, A. Varricchio, M. Capasso, T. Lanzillo, F. Manganelli, C. Mariello, F. Siano, M. R. Pagliuca, et al.
The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial
J. Am. Coll. Cardiol. Intv., June 1, 2009; 2(6): 515 - 523.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. S. Brar, M. B. Leon, G. W. Stone, R. Mehran, J. W. Moses, S. K. Brar, and G. Dangas
Use of Drug-Eluting Stents in Acute Myocardial Infarction: A Systematic Review and Meta-Analysis
J. Am. Coll. Cardiol., May 5, 2009; 53(18): 1677 - 1689.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
Ph. G. Steg, K. A.A. Fox, K. A. Eagle, M. Furman, F. Van de Werf, G. Montalescot, S. G. Goodman, A. Avezum, W. Huang, J. M. Gore, et al.
Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events
Eur. Heart J., February 1, 2009; 30(3): 321 - 329.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc IntervHome page
L. O. Jensen, M. Maeng, P. Thayssen, A. Kaltoft, H. H. Tilsted, M. Bottcher, J. F. Lassen, K. N. Hansen, L. R. Krusell, K. Rasmussen, et al.
Clinical Outcome After Primary Percutaneous Coronary Intervention With Drug-Eluting and Bare Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction
Circ Cardiovasc Interv, December 1, 2008; 1(3): 176 - 184.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc IntervHome page
N. Kukreja, Y. Onuma, H. Garcia-Garcia, J. Daemen, R. van Domburg, and P. W. Serruys
Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Long-Term Outcome After Bare Metal and Drug-Eluting Stent Implantation
Circ Cardiovasc Interv, October 1, 2008; 1(2): 103 - 110.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Kelbaek, L. Thuesen, S. Helqvist, P. Clemmensen, L. Klovgaard, A. Kaltoft, B. Andersen, H. Thuesen, T. Engstrom, H. E. Botker, et al.
Drug-Eluting Versus Bare Metal Stents in Patients With ST-Segment-Elevation Myocardial Infarction: Eight-Month Follow-Up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) Trial
Circulation, September 9, 2008; 118(11): 1155 - 1162.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
B. R. Brodie, T. Stuckey, W. Downey, A. Humphrey, B. Bradshaw, C. Metzger, J. Hermiller, F. Krainin, S. Juk, B. Cheek, et al.
Outcomes and Complications With Off-Label Use of Drug-Eluting Stents: Results From the STENT (Strategic Transcatheter Evaluation of New Therapies) Group
J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 405 - 414.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2355 - 2369.
[Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
M. H. Shishehbor, R. Amini, L. P.J. Oliveria, I. M. Singh, P. Kelly, D. L. Bhatt, S. R. Kapadia, S. G. Ellis, P. L. Whitlow, and S. J. Brener
Comparison of Drug-Eluting Stents Versus Bare-Metal Stents for Treating ST-Segment Elevation Myocardial Infarction
J. Am. Coll. Cardiol. Intv., June 1, 2008; 1(3): 227 - 232.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
E. L. Hannan, M. Racz, G. Walford, D. R. Holmes, R. H. Jones, S. Sharma, S. Katz, and S. B. King III
Drug-Eluting Versus Bare-Metal Stents in the Treatment of Patients With ST-Segment Elevation Myocardial Infarction
J. Am. Coll. Cardiol. Intv., April 1, 2008; 1(2): 129 - 135.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, P. Clopton, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, J. D. Knoke, W. Y.W. Lew, J. A.C. Lima, et al.
Highlights of the Year in JACC 2007
J. Am. Coll. Cardiol., January 29, 2008; 51(4): 490 - 512.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
X. Pan
Concerns in the SESAMI Trial
J. Am. Coll. Cardiol., January 22, 2008; 51(3): 329 - 330.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Menichelli
Reply
J. Am. Coll. Cardiol., January 22, 2008; 51(3): 330 - 330.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
A. Kastrati, A. Dibra, C. Spaulding, G. J. Laarman, M. Menichelli, M. Valgimigli, E. Di Lorenzo, C. Kaiser, I. Tierala, J. Mehilli, et al.
Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction
Eur. Heart J., November 2, 2007; 28(22): 2706 - 2713.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Valgimigli, G. Campo, C. Arcozzi, P. Malagutti, R. Carletti, F. Ferrari, D. Barbieri, G. Parrinello, G. Percoco, and R. Ferrari
Two-Year Clinical Follow-Up After Sirolimus-Eluting Versus Bare-Metal Stent Implantation Assisted by Systematic Glycoprotein IIb/IIIa Inhibitor Infusion in Patients With Myocardial Infarction: Results From the STRATEGY Study
J. Am. Coll. Cardiol., July 10, 2007; 50(2): 138 - 145.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
H. V. Anderson, R. W. Smalling, and T. D. Henry
Drug-Eluting Stents for Acute Myocardial Infarction
J. Am. Coll. Cardiol., May 15, 2007; 49(19): 1931 - 1933.
[Full Text] [PDF]


 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement